CoChat

Human tau increases amyloid β plaque size but not amyloid β‐mediated synapse loss in a novel mouse model of Alzheimer's disease

Open access
Jackson, Rosemary J., Rudinskiy, Nikita, Herrmann, Abigail G., Croft, Shaun, Kim, JeeSoo Monica, Petrova, Veselina, Ramos‐Rodriguez, Juan Jose, Pitstick, Rose, Wegmann, Susanne, Garcia‐Alloza, Monica, Carlson, George A., Hyman, Bradley T., Spires‐Jones, Tara L. · 2016 · European Journal of Neuroscience
Cited by 109

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Abstract

Alzheimer's disease is characterized by the presence of aggregates of amyloid beta (Aβ) in senile plaques and tau in neurofibrillary tangles, as well as marked neuron and synapse loss. Of these pathological changes, synapse loss correlates most strongly with cognitive decline. Synapse loss occurs prominently around plaques due to accumulations of oligomeric Aβ. Recent evidence suggests that tau may also play a role in synapse loss but the interactions of Aβ and tau in synapse loss remain to be determined. In this study, we generated a novel transgenic mouse line, the APP/PS 1/rT g21221 line, by crossing APP/PS 1 mice, which develop Aβ‐plaques and synapse loss, with rT g21221 mice, which overexpress wild‐type human tau. When compared to the APP/PS 1 mice without human tau, the cross‐sectional area of ThioS+ dense core plaques was increased by ~50%. Along with increased plaque size, we observed an increase in plaque‐associated dystrophic neurites containing misfolded tau, but there was no exacerbation of neurite curvature or local neuron loss around plaques. Array tomography analysis similarly revealed no worsening of synapse loss around plaques, and no change in the accumulation of Aβ at synapses. Together, these results indicate that adding human wild‐type tau exacerbates plaque pathology and neurite deformation but does not exacerbate plaque‐associated synapse loss.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ejn.13442

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 109

Metadata

Authors
Jackson, R. J., Rudinskiy, N., Herrmann, A. G., Croft, S., Kim, J. M., Petrova, V., Ramos‐Rodriguez, J. J., Pitstick, R., Wegmann, S., Garcia‐Alloza, M., Carlson, G. A., Hyman, B. T., & Spires‐Jones, T. L.
Venue
European Journal of Neuroscience
Publisher
Wiley
Published
2016-11-12
Volume
44
Issue
12
Pages
3056-3066
ISSN
  • 0953-816X (ISSN-L)
  • 1460-9568
OpenAlex
W2534837518
Cited by
109
References
34
FWCI
7.07
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human tau increases amyloid β plaque size but not amyloid β‐mediated synapse loss in a novel mouse model of Alzheimer's disease. https://app.cochat.ai/papers/10.1111/ejn.13442
The paper
Jackson, R. J., Rudinskiy, N., Herrmann, A. G., Croft, S., Kim, J. M., Petrova, V., Ramos‐Rodriguez, J. J., Pitstick, R., Wegmann, S., Garcia‐Alloza, M., Carlson, G. A., Hyman, B. T., & Spires‐Jones, T. L. (2016). Human tau increases amyloid β plaque size but not amyloid β‐mediated synapse loss in a novel mouse model of Alzheimer's disease. European Journal of Neuroscience. https://doi.org/10.1111/ejn.13442

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.